Evidence mapPaperPMID 39712965Full record

ArticleGenetics in medicine open2024

Cancer genetic counseling in Chile: Addressing barriers, confronting challenges, and seizing opportunities in an underserved Latin American Community.

Ricardo Fernández-Ramires, Sebastián Morales-Pison, Guilherme Gischkow Rucatti, César Echeverría, Esteban San Martín, Francisco Cammarata-Scalisi, Alexis Salas-Burgos, Daniela Adorno-Farias, Wilfredo Alejandro González-Arriagada, Yolanda Espinosa-Parrilla and 7 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ricardo Fernández-RamiresFacultad de Medicina y Ciencias de la Salud. Universidad Mayor. Santiago, Chile.
Sebastián Morales-PisonFacultad de Medicina y Ciencias de la Salud. Universidad Mayor. Santiago, Chile.
Guilherme Gischkow RucattiFacultad de Medicina y Ciencias de la Salud. Universidad Mayor. Santiago, Chile.
César EcheverríaGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Esteban San MartínGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Francisco Cammarata-ScalisiGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Alexis Salas-BurgosGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Daniela Adorno-FariasGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Wilfredo Alejandro González-ArriagadaGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Yolanda Espinosa-ParrillaGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Daniela Zapata-ContrerasGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.
Gabriela NoreseUniversidad de Buenos Aires, Escobar, Argentina.
Conxi LázaroPrograma de Cáncer Hereditario. Instituto Catalán de Oncología. Barcelona, Spain.
Sara GonzálezPrograma de Cáncer Hereditario. Instituto Catalán de Oncología. Barcelona, Spain.
Miguel Angel PujanaProCURE, Instituto Catalán de Oncología, Instituto de Investigación Biomédica Bellvitge (IDIBELL), Barcelona, España.
Yasser SullcahuamanInstituto Nacional de Enfermedades Neoplasicas (INEN). Lima, Perú.
Sonia MargaritGrupo Chileno de Cáncer Hereditario (GCCH), Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Despite the rapid advancements in genomics and the enactment of a new cancer law in Chile, the implementation of cancer genetic counseling continues to face significant challenges because of limited resources and infrastructure. Methods: We conducted a survey targeting health care providers who offer genetic counseling to patients with cancer and possess training in genetics and counseling. Additionally, we distributed a separate survey to high-risk patients associated with an advocacy group to gather insights on their perceptions of and experiences with cancer genetic counseling. Results: Among the surveyed providers, 21% were nonmedical professionals who developed their skills through postgraduate continuing education programs. Germline testing was not performed in 47% of cases. Among the participants, 37% considered genetic counseling important for understanding the cause of their cancer, 25% valued knowing their risk of developing future tumors, and 33% believed it would benefit their current cancer treatment. Just over half of the patients (54%) had access to genetic counseling. Among those that received genetic counseling, 85% found it beneficial. Conclusion: In Chile, barriers to genetic counseling persist, particularly in rural areas and because of a shortage of trained professionals. Public policies recognizing genetic counseling's importance are crucial, along with expanding training and infrastructure. Understanding patient perceptions and increasing the number of trained genetic counseling into cancer care, educating clinicians, and advocating for increased access are key steps for enhancing cancer treatment effectiveness in Chile.

Indexed as

Genetic counselingHereditary cancerSurvey

Identifiers

PMID39712965
PMCPMC11658315

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.